Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
04/15/2008 | US7358360 Risedronate sodium having a very low content of iron |
04/15/2008 | US7358358 includes (1) beta -(10-phenothiazyl)propoxy phosphonic acid; (2) beta -(10-phenothiazyl)propyl-phosphonic acid; and (3) beta -(10-phenothiazyl)propionate phosphonic acid; p-type redox promoters and redox chromophores |
04/15/2008 | US7358250 Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity |
04/15/2008 | US7358209 Polymerisation catalysts |
04/15/2008 | CA2337452C Process for the preparation of 4,5-diamino shikimic acid derivatives |
04/15/2008 | CA2240107C Novel diphenylarsines |
04/15/2008 | CA2176525C Fluorescent compounds |
04/10/2008 | WO2008042240A2 Enantiomerically pure phosphoindoles as hiv inhibitors |
04/10/2008 | WO2008041029A1 Chiral phosphorus compound |
04/10/2008 | WO2007145940A3 High-throughput rna structure analysis |
04/10/2008 | WO2007132482A3 Novel process for the preparation of pitavastatin and its pharmaceutically acceptable salts |
04/10/2008 | US20080085458 alkylsulfonyloximes are reactive nonionic photoacid generators; thermally stable at high bake temp; chemically stable; high photosensitivity not only at Deep-UV range but longer wavelengths such as i-line (365 nm); acid catalyst in chemically amplified photoresist; sulfonylation of oximes; color filter |
04/10/2008 | US20080085263 Liquid Depot Formulations |
04/10/2008 | US20080083606 Separation of acids from chemical reaction mixtures by means of ionic liquids |
04/10/2008 | CA2664396A1 Enantiomerically pure phosphoindoles as hiv inhibitors |
04/09/2008 | EP1908829A1 Oligonucleotide probe |
04/09/2008 | EP1907403A2 Antiviral compounds |
04/09/2008 | EP1907402A2 Bisphosphines |
04/09/2008 | EP1907401A1 Stable water soluble composition containing lysophosphatidylethanolamine and lecithin |
04/09/2008 | CN101160272A Hydroformylation process with improved iso-selectivity |
04/09/2008 | CN101157705A New technique for preparing hexachloride ring polyphosphazenes |
04/09/2008 | CN101157704A Method for micro-wave synthesis of hexachloride ring polyphosphazenes |
04/09/2008 | CN101157703A Adenine bisphosphonate and preparation method thereof and application in pharmaceutical preparations |
04/09/2008 | CN101157702A Synthesis and production of novel environment-friendly type non-bittern combustion inhibitor |
04/09/2008 | CN101157592A A process for the separation of acids from reaction mixtures by ion liquid |
04/09/2008 | CN101156861A Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
04/09/2008 | CN100379747C Ligands |
04/09/2008 | CN100379709C Methods of producing phosphitylated compounds |
04/08/2008 | US7355073 Reacting phosphine with diimine; oxygen-free; cyclization |
04/08/2008 | US7355072 Hydrogenation, hydrogenolysis, hydrosilylation, hydroboration, hydroamination, hydroformylation, hydroacylation hydrocaroboxylation, hydroesterification hydrocarboxamidation, isomerization, metathesis, and dehydrogenation catalysts |
04/08/2008 | US7354966 Compounds for use as surfactants |
04/08/2008 | US7354939 Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto |
04/08/2008 | US7354895 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
04/08/2008 | CA2220188C Vinylpyrrolidinon cephalosporin derivatives |
04/07/2008 | CA2579596A1 Preparation of oseltamivir phosphate (tamiflu(r)) and intermediates starting from d-glucose or d-xylose |
04/03/2008 | WO2008039085A1 Triphenylphosphonium thionitrite nitric oxide donors |
04/03/2008 | WO2008038651A1 Phosphate ester compound, metal salt thereof, dental material, and demtal composition |
04/03/2008 | WO2008014139A3 Olefin oligomerization catalysts and methods of using same |
04/03/2008 | WO2008010985A3 Phosphorus derivatives as histone deacetylase inhibitors |
04/03/2008 | WO2007110624A3 Immobilised reagent |
04/03/2008 | US20080081909 Process for producing olefins |
04/03/2008 | US20080081902 Capping, polymerizing and separating failure sequences; kits for purifying oligonucleotides and polynucleotides |
04/03/2008 | US20080081857 Method of making a thermoplastic composition containing an antistatic agent |
04/03/2008 | DE102006045814A1 Unsymmetrisch substituierte Phosphinsäuren Asymmetrically substituted phosphinic |
04/03/2008 | CA2664744A1 Triphenylphosphonium thionitrite nitric oxide donors |
04/03/2008 | CA2664572A1 Substituted piperidinophenyl oxazolidinones |
04/02/2008 | EP1905776A1 Asymmetrical substituted phosphine acids |
04/02/2008 | EP1905511A2 Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions |
04/02/2008 | EP1904506A1 Antiviral compounds |
04/02/2008 | EP1904460A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
04/02/2008 | EP1904057A2 Methods of treatment using hydroquinone ansamycins |
04/02/2008 | EP1651655B1 A process for the preparation of acylphosphines |
04/02/2008 | CN101155818A Substituted propane phosphinic acid esters |
04/02/2008 | CN101155768A Improved method for producing biphenols from monophenols |
04/02/2008 | CN101153047A Substituted benzene oxygen acetoxy fragrant heterocyclic radical hydrocarbon radical phosphinic acid ester salt having disinfecting and weeding function and production thereof |
04/02/2008 | CN101153046A Boronation phosphoryl phosphor hydrazide ester, preparing method and application of the same |
04/02/2008 | CN101152160A Oral pharmaceutical formulation containing ibandronate |
04/02/2008 | CN100378112C Novel carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
04/01/2008 | US7351868 Carbonylation of polyunsaturated olefin in the presence of a transition metal-triorganophosphine ligand complex having a ligand cone angle greater than 135 degrees or a pKa of less than 8.3 to reduce phosphonium production; converting phosphonium to phosphines with inert gas, hydrogen, or synthesis gas |
04/01/2008 | US7351845 Transition metal polymerization catalysts, their synthesis and use in olefin polymerization |
04/01/2008 | US7351844 Adjust diffusion of oxygen; respiratory system disorders; cardiovascular disorders |
04/01/2008 | US7351835 Organic molecular cataylst having binaphthol skeleton and processes for producing the same and application thereof |
04/01/2008 | US7351830 Formed by selective phosphorylation of phenpanstatin with tetrabutylammonium dihydrogen phosphate and dicyclohexylcarbodiimide in pyridine followed by cation exchange; cancer cell inhibitors |
04/01/2008 | US7351829 Compounds on the basis of 2- and 4-chromenylidene-merocyanines respectively, and their use |
04/01/2008 | US7351725 For therapy of immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection |
04/01/2008 | US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis |
04/01/2008 | US7351691 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals |
04/01/2008 | US7351428 Phosphatidyl oligoglycerols |
04/01/2008 | US7351399 Conversion by human liver microsomes to MPO3H2; hepatitis, cancer, liver fibrosis, malaria, other viral and parasitic infections, and metabolic diseases where the liver is responsible for the overproduction of the biochemical end product, diabetes; enhanced oral drug delivery |
04/01/2008 | US7351339 Using an auxiliary base to form a salt with the acid which is liquid at low enough temperature so that value product does not decompose during the removal of the liquid salt; e.g. acid catalyst removal; ionic liquids |
03/27/2008 | WO2008035687A1 METHOD FOR PRODUCING PHOSPHORUS-CONTAINING α-AMINO ACID AND PRODUCTION INTERMEDIATE THEREOF |
03/27/2008 | WO2008035131A1 An improved process for the preparation of bisphosphonic acid |
03/27/2008 | WO2008008660A3 Cyclopentane derivatives as antiglaucoma agents |
03/27/2008 | WO2006065960A3 Cationic liposomes comprising a charge neutral compound and a cationic phospholipid |
03/27/2008 | US20080076944 Purification of Phosphorus Chelate Ligands |
03/27/2008 | US20080076917 Intermediates of 2-Substituted Carbapenem Derivatives and Process for Production Thereof |
03/27/2008 | US20080076893 Hydrophilic siloxanyl monomers with pendant polymerizable groups |
03/27/2008 | US20080076833 Phosphorylated Polyphenols as Colour-Stable Agents |
03/27/2008 | US20080076738 antiviral: improved pharmacokinetics |
03/27/2008 | US20080076736 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
03/27/2008 | US20080076188 Luminescent compounds |
03/27/2008 | CA2652420A1 Process for the synthesis of ibandronate sodium |
03/26/2008 | EP1902078A1 (meth)acrylamide phosphorus monomer composition |
03/26/2008 | EP1902004A2 Onium-alkylsulfonate production method |
03/26/2008 | EP1658298B1 Phosphorus-containing imidazolines and metal complexes thereof |
03/26/2008 | EP1592719B1 Conjugation reactions |
03/26/2008 | EP1592698B1 Phosphine compound, intermediate, palladium-complex, and use thereof |
03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
03/26/2008 | CN101148457A Phosphorus-containing tri-functional group liquid alicyclic epoxy compound and preparation method thereof |
03/26/2008 | CN101148456A Organic phosphoric acid catalyst and its preparation method and application |
03/26/2008 | CN101148434A Method for synthesizing pentadecane triphenyl phosphonium salt |
03/26/2008 | CN100377415C Electrode stabilizing agent |
03/26/2008 | CN100376589C Trimethyl phosphite producing process |
03/26/2008 | CN100376588C High purity yolk lecithin preparation method |
03/26/2008 | CN100376585C Blocked mercaptosilane coupling agents for filled rubber |
03/26/2008 | CN100376584C Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony and uses thereof |
03/26/2008 | CN100376570C Dioxolane analogs for improved inter-cellular delivery |
03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
03/25/2008 | US7348458 Phosphonium salt, organically modified layered silicate containing the phosphonium salt and composition thereof |
03/25/2008 | US7348396 Modified polyethylenephosphinic acids and their salts |